Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125463672 | 12546367 | 2 | F | 20160528 | 20160706 | 20160711 | 20160728 | PER | US-BAYER-2016-120111 | BAYER | 63.00 | YR | A | F | Y | 0.00000 | 20160728 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125463672 | 12546367 | 1 | SS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | UNK | 0 | NEBULISER SOLUTION | |||||||||
| 125463672 | 12546367 | 2 | SS | OPSUMIT | MACITENTAN | 1 | Oral | 10 MG, QD | 0 | 10 | MG | TABLET | QD | ||||||
| 125463672 | 12546367 | 3 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 125463672 | 12546367 | 4 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 800 ?G, BID | 0 | 800 | UG | TABLET | BID | ||||||
| 125463672 | 12546367 | 5 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 1400 ?G, BID | 0 | 1400 | UG | TABLET | BID | ||||||
| 125463672 | 12546367 | 6 | PS | RIOCIGUAT (GUANYLATE CYCLASE STIMULATOR) | RIOCIGUAT | 1 | Unknown | 2 MG, TID | 204819 | 2 | MG | TID | |||||||
| 125463672 | 12546367 | 7 | C | WARFARIN | WARFARIN | 1 | UNK | 0 | |||||||||||
| 125463672 | 12546367 | 8 | C | ALBUTEROL. | ALBUTEROL | 1 | UNK | 0 | |||||||||||
| 125463672 | 12546367 | 9 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | UNK | 0 | |||||||||||
| 125463672 | 12546367 | 10 | C | TEMAZEPAM. | TEMAZEPAM | 1 | UNK | 0 | |||||||||||
| 125463672 | 12546367 | 11 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | UNK | 0 | |||||||||||
| 125463672 | 12546367 | 12 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | UNK | 0 | |||||||||||
| 125463672 | 12546367 | 13 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 125463672 | 12546367 | 14 | C | POTASSIUM | POTASSIUM | 1 | UNK | 0 | |||||||||||
| 125463672 | 12546367 | 15 | C | DIGOXIN. | DIGOXIN | 1 | UNK | 0 | |||||||||||
| 125463672 | 12546367 | 16 | C | FENOFIBRATE. | FENOFIBRATE | 1 | UNK | 0 | |||||||||||
| 125463672 | 12546367 | 17 | C | OLOPATADINE HYDROCHLORIDE. | OLOPATADINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 125463672 | 12546367 | 18 | C | LORATADINE. | LORATADINE | 1 | UNK | 0 | |||||||||||
| 125463672 | 12546367 | 19 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125463672 | 12546367 | 1 | Pulmonary arterial hypertension |
| 125463672 | 12546367 | 2 | Pulmonary arterial hypertension |
| 125463672 | 12546367 | 3 | Pulmonary arterial hypertension |
| 125463672 | 12546367 | 4 | Pulmonary arterial hypertension |
| 125463672 | 12546367 | 5 | Pulmonary arterial hypertension |
| 125463672 | 12546367 | 6 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125463672 | 12546367 | Back pain | |
| 125463672 | 12546367 | Mastitis | |
| 125463672 | 12546367 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125463672 | 12546367 | 2 | 20140825 | 0 | ||
| 125463672 | 12546367 | 3 | 20160426 | 0 | ||
| 125463672 | 12546367 | 4 | 20160601 | 0 |